{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:22:38Z","timestamp":1789060958474,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interstitial lung disease (ILD) and pulmonary sarcoidosis are common respiratory diseases that are difficult to diagnose and costly to treat. Adolescents and young adults (AYAs) aged 15\u201339\u00a0years are frequently overlooked in global burden estimates despite their unique epidemiological and societal implications. Comprehensive global burden estimates are lacking. To address this gap, we analysed the results of the Global Burden of Disease Study (GBD) 2019, focusing on Disability-Adjusted Life Years (DALYs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the GBD 2019 dataset, we calculated age-standardised rate of incidence, mortality, and DALYs and their average annual percentage change from 1990 to 2019 across various factors, including sex, socio-demographic index (SDI), and geographic region. Decomposition analyses explored the impacts of population growth, changing age structures, and epidemiological changes on ILD incidence, DALYs, and mortality in AYAs globally and across different SDI and GBD regions.interstitial lung disease and pulmonary sarcoidosis among adolescents and young adults trends from 2020 to 2049 were predicted using Bayesian Age-Period-Cohort (BAPC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2019, there were 2.6 million cases of ILD and pulmonary sarcoidosis in AYAs, and 3,428 deaths were attributed to these diseases. Age-standardised incidence and DALY rates significantly increased between 1990 and 2019. Females experienced higher rates than males. Standardised DALY rates decreased in high and middle\u2013high SDI countries but increased in low, middle\u2013low, and low-SDI countries. The primary reason was population growth, significantly impacting areas in the lower SDI quintiles.The BAPC model projected a gradual increase in the interstitial lung disease and pulmonary sarcoidosis in\u00a0adolescents and\u00a0young adults burden from 2020 to 2049.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides recent epidemiological data on the burden of ILD and pulmonary sarcoidosis in AYAs. These findings highlight the importance of targeted control measures to reduce the burden in this age group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-025-03141-x","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:34:07Z","timestamp":1758882847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global Burden of Disease of interstitial lung disease and pulmonary sarcoidosis in adolescents and young adults (1990\u20132019), and projections for the next 30\u00a0years"],"prefix":"10.1186","volume":"30","author":[{"given":"Xiaoshuang","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"3","key":"3141_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccm.2023.06.003","volume":"44","author":"M Sharp","year":"2023","unstructured":"Sharp M, Mustafa AM, Farah N, Bonham CA. Interstitial lung disease and sarcoidosis. Clin Chest Med. 2023;44(3):575\u201384. https:\/\/doi.org\/10.1016\/j.ccm.2023.06.003.","journal-title":"Clin Chest Med"},{"issue":"1","key":"3141_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3760\/cma.j.cn112147-20231021-00252","volume":"47","author":"H Huang","year":"2024","unstructured":"Huang H. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi. Chin J Tuberc Respir Dis. 2024;47(1):44\u20139. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20231021-00252.","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"19","key":"3141_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/jama.2024.3669","volume":"331","author":"TM Maher","year":"2024","unstructured":"Maher TM. Interstitial lung disease: a review. JAMA. 2024;331(19):1655\u201365. https:\/\/doi.org\/10.1001\/jama.2024.3669.","journal-title":"JAMA"},{"issue":"9","key":"3141_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","volume":"158","author":"G Raghu","year":"2013","unstructured":"Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, et al. Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013;158(9):641\u20139. https:\/\/doi.org\/10.7326\/0003-4819-158-9-201305070-00003.","journal-title":"Ann Intern Med"},{"issue":"5","key":"3141_CR5","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1183\/13993003.01537-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, et al. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction. Eur Respir J. 2015;46(5):1370\u20137. https:\/\/doi.org\/10.1183\/13993003.01537-2014.","journal-title":"Eur Respir J"},{"issue":"4","key":"3141_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46(4):1113\u201330. https:\/\/doi.org\/10.1183\/13993003.02316-2014.","journal-title":"Eur Respir J"},{"issue":"1","key":"3141_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00630-2021","volume":"8","author":"N Jeganathan","year":"2021","unstructured":"Jeganathan N, Sathananthan M. The prevalence and burden of interstitial lung diseases in the USA. ERJ Open Res. 2021;8(1):00630\u20132021. https:\/\/doi.org\/10.1183\/23120541.00630-2021.","journal-title":"ERJ Open Res"},{"issue":"7","key":"3141_CR8","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1007\/s12325-021-01786-8","volume":"38","author":"AL Olson","year":"2021","unstructured":"Olson AL, Patnaik P, Hartmann N, Bohn RL, Garry EM, Wallace L. Prevalence and incidence of chronic fibrosing interstitial lung diseases with a progressive phenotype in the United States estimated in a large claims database analysis. Adv Ther. 2021;38(7):4100\u201314. https:\/\/doi.org\/10.1007\/s12325-021-01786-8.","journal-title":"Adv Ther"},{"issue":"8","key":"3141_CR9","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26\u201351. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3141_CR10","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1513\/AnnalsATS.202009-1134OC","volume":"18","author":"LM Fidler","year":"2021","unstructured":"Fidler LM, Gershon A, Fisher JH, Stanbrook MB, To T, Balter M. Hospitalizations in sarcoidosis: a cohort study of a universal healthcare population. Ann Am Thorac Soc. 2021;18(11):1786\u201394. https:\/\/doi.org\/10.1513\/AnnalsATS.202009-1134OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"3141_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","volume":"26","author":"EV Arkema","year":"2020","unstructured":"Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527\u201334. https:\/\/doi.org\/10.1097\/MCP.0000000000000715.","journal-title":"Curr Opin Pulm Med"},{"issue":"9","key":"3141_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2022.1570","volume":"327","author":"JA Belperio","year":"2022","unstructured":"Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R, et al. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA. 2022;327(9):856\u201367. https:\/\/doi.org\/10.1001\/jama.2022.1570.","journal-title":"JAMA"},{"issue":"1","key":"3141_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12890-022-01922-2","volume":"22","author":"AW Wong","year":"2022","unstructured":"Wong AW, Koo J, Ryerson CJ, Sadatsafavi M, Chen W. A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies. BMC Pulm Med. 2022;22(1):148. https:\/\/doi.org\/10.1186\/s12890-022-01922-2.","journal-title":"BMC Pulm Med"},{"issue":"11","key":"3141_CR14","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1513\/AnnalsATS.202011-1467OC","volume":"18","author":"LJ Harper","year":"2021","unstructured":"Harper LJ, Love G, Singh R, Smith A, Culver DA, Thornton JD. Barriers to care among patients with sarcoidosis: a qualitative study. Ann Am Thorac Soc. 2021;18(11):1832\u20138. https:\/\/doi.org\/10.1513\/AnnalsATS.202011-1467OC.","journal-title":"Ann Am Thorac Soc"},{"key":"3141_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m234","volume":"368","author":"X Li","year":"2020","unstructured":"Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ (Clinical research ed). 2020;368:m234. https:\/\/doi.org\/10.1136\/bmj.m234.","journal-title":"BMJ (Clinical research ed)"},{"issue":"10258","key":"3141_CR16","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"Lancet"},{"issue":"10258","key":"3141_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBD 2019 Demographics Collaborators","year":"2020","unstructured":"GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1160\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(20)30977-6.","journal-title":"Lancet"},{"issue":"3","key":"3141_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z.","journal-title":"Stat Med"},{"issue":"6","key":"3141_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003138","volume":"17","author":"X Cheng","year":"2020","unstructured":"Cheng X, Yang Y, Schwebel DC, Liu Z, Li L, Cheng P, et al. Population ageing and mortality during 1990\u20132017: a global decomposition analysis. PLoS Med. 2020;17(6):e1003138. https:\/\/doi.org\/10.1371\/journal.pmed.1003138.","journal-title":"PLoS Med"},{"issue":"6","key":"3141_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/thoraxjnl-2020-216732","volume":"77","author":"X Ma","year":"2022","unstructured":"Ma X, Zhu L, Kurche JS, Xiao H, Dai H, Wang C. Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019. Thorax. 2022;77(6):596\u2013605. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216732.","journal-title":"Thorax"},{"key":"3141_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106415","volume":"183","author":"L Ses\u00e9","year":"2021","unstructured":"Ses\u00e9 L, Caliez J, Annesi-Maesano I, Cottin V, Pesce G, Didier M, et al. Low income and outcome in idiopathic pulmonary fibrosis: an association to uncover. Respir Med. 2021;183:106415. https:\/\/doi.org\/10.1016\/j.rmed.2021.106415.","journal-title":"Respir Med"},{"issue":"2","key":"3141_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1164\/rccm.202208-1470LE","volume":"207","author":"JA Rose","year":"2023","unstructured":"Rose JA, Planchart Ferretto MA, Maeda AH, Perez Garcia MF, Carmichael NE, Gulati S, et al. Progressive interstitial lung disease in relatives of patients with pulmonary fibrosis. Am J Respir Crit Care Med. 2023;207(2):211\u20134. https:\/\/doi.org\/10.1164\/rccm.202208-1470LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3141_CR23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","volume":"201","author":"LJ Harper","year":"2020","unstructured":"Harper LJ, Gerke AK, Wang XF, Ribeiro Neto ML, Baughman RP, Beyer K, et al. Income and other contributors to poor outcomes in U.S. patients with sarcoidosis. Am J Respir Crit Care Med. 2020;201(8):955\u201364. https:\/\/doi.org\/10.1164\/rccm.201906-1250OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10309","key":"3141_CR24","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0140-6736(21)01826-2","volume":"398","author":"KA Johannson","year":"2021","unstructured":"Johannson KA, Chaudhuri N, Adegunsoye A, Wolters PJ. Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet. 2021;398(10309):1450\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(21)01826-2.","journal-title":"Lancet"},{"issue":"1","key":"3141_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S2213-2600(22)00356-3","volume":"11","author":"A Manfredi","year":"2023","unstructured":"Manfredi A, Salvarani C, Sebastiani M. Rituximab for connective tissue disease-associated interstitial lung disease. Lancet Respir Med. 2023;11(1):3\u20134. https:\/\/doi.org\/10.1016\/S2213-2600(22)00356-3.","journal-title":"Lancet Respir Med"},{"issue":"8","key":"3141_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMc1807508","volume":"379","author":"KH Shin","year":"2018","unstructured":"Shin KH, Shin SW. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;379(8):795\u20136. https:\/\/doi.org\/10.1056\/NEJMc1807508.","journal-title":"N Engl J Med"},{"key":"3141_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.socscimed.2017.01.044","volume":"176","author":"TJ Kim","year":"2017","unstructured":"Kim TJ, Vonneilich N, L\u00fcdecke D, von dem Knesebeck O. Income, financial barriers to health care and public health expenditure: a multilevel analysis of 28 countries. Soc Sci Med. 2017;176:158\u201365. https:\/\/doi.org\/10.1016\/j.socscimed.2017.01.044.","journal-title":"Soc Sci Med"},{"issue":"11","key":"3141_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1164\/rccm.202103-0559UP","volume":"203","author":"AJ Podolanczuk","year":"2021","unstructured":"Podolanczuk AJ, Wong AW, Saito S, Lasky JA, Ryerson CJ, Eickelberg O. Update in interstitial lung disease 2020. Am J Respir Crit Care Med. 2021;203(11):1343\u201352. https:\/\/doi.org\/10.1164\/rccm.202103-0559UP.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03141-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03141-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:34:08Z","timestamp":1758882848000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03141-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3141"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03141-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5787561\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"878"}}